- Home
- PMCB vs SBFM Comparison
PMCB vs SBFM Comparison
Compare PMCB & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- SBFM
- Stock Information
- Founded
- PMCB 1996
- SBFM 2006
- Country
- PMCB United States
- SBFM United States
- Employees
- PMCB N/A
- SBFM N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- PMCB Health Care
- SBFM Health Care
- Exchange
- PMCB Nasdaq
- SBFM Nasdaq
- Market Cap
- PMCB 6.7M
- SBFM 6.7M
- IPO Year
- PMCB N/A
- SBFM N/A
- Fundamental
- Price
- PMCB $1.04
- SBFM $1.67
- Analyst Decision
- PMCB
- SBFM Strong Buy
- Analyst Count
- PMCB 0
- SBFM 1
- Target Price
- PMCB N/A
- SBFM $15.00
- AVG Volume (30 Days)
- PMCB 121.2K
- SBFM 62.2K
- Earning Date
- PMCB 09-15-2025
- SBFM 11-04-2025
- Dividend Yield
- PMCB N/A
- SBFM N/A
- EPS Growth
- PMCB N/A
- SBFM N/A
- EPS
- PMCB 0.01
- SBFM N/A
- Revenue
- PMCB N/A
- SBFM $36,341,741.00
- Revenue This Year
- PMCB N/A
- SBFM $32.20
- Revenue Next Year
- PMCB N/A
- SBFM $32.74
- P/E Ratio
- PMCB $163.65
- SBFM N/A
- Revenue Growth
- PMCB N/A
- SBFM 19.22
- 52 Week Low
- PMCB $0.80
- SBFM $1.17
- 52 Week High
- PMCB $2.42
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- PMCB 52.01
- SBFM 67.82
- Support Level
- PMCB $0.94
- SBFM $1.50
- Resistance Level
- PMCB $1.06
- SBFM $1.67
- Average True Range (ATR)
- PMCB 0.08
- SBFM 0.08
- MACD
- PMCB 0.00
- SBFM 0.01
- Stochastic Oscillator
- PMCB 38.16
- SBFM 73.44
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.